In this work, we combined clinical and blood transcriptional data, together with an extensive analysis of patient-derived monoclonal antibodies, to understand the origin and immunopathology related to anti-DNase1L3 antibodies in SLE. This evidence concerns the gene DNASE1L3 and systemic lupus erythematosus.